OCT imaging showing before and after images of a heavily calcified coronary artery treated using the Shockwave intravascular lithotripsy system. #TCT2021
November 10, 2021
Shockwave Unveils First One-Year Results of Coronary Intravascular Lithotripsy
November 10, 2021 — Shockwave Medical a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely…
Read More
An Abbott Vascular survey found one in four physicians surveyed feel lack of technology makes an accurate diagnosis of coronary artery disease and peripheral artery disease a key obstacle to an accurate diagnosis. Getty Images
November 10, 2021
Research Finds Challenges in Vascular Disease Symptom Recognition and Diagnostic Testing Impacts Patient Satisfaction
November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s…
Read More
November 10, 2021
Medicare Increases Hospital Outpatient Payment for Peripheral Intravascular Lithotripsy
November 10, 2021 — Shockwave Medical, a developer of Intravascular Lithotripsy (IVL) to treat complex calcified…
Read More
November 10, 2021
Ancora Heart AccuCinch System Shows Positive 12 Month Outcomes in Multi-study Analysis
November 10, 2021 — Ancora Heart Inc., a company developing a novel therapy to address heart failure, announced results…
Read More
#TCT2021 - Philips Image Guided Therapy System – Azurion
November 10, 2021
Philips Announces New Innovations and Clinical Data Supporting the Treatment of Patients with Cardiovascular Disease
November 10, 2021 — Philips Healthcare announced North American availability of new innovations in its portfolio of…
Read More
November 10, 2021
Philips to Expand Its Cardiac Diagnostics and Monitoring Portfolio With the Acquisition of Cardiologs
November 10, 2021 — Philips, a global leader in health technology, announced that it has signed an agreement to acquire…
Read More
TCT 2021 Announces Late-Breaking Clinical Trials
November 10, 2021
Links to all the TCT 2021 Late-Breaking Clinical Trials
November 10, 2021 — There were nine late-breaking trials and 13 late-breaking science presentations at the 2021…
Read More
The Teleflex Manta large bore vascular closure device #TCT2021
November 09, 2021
Plug-based Vascular Closure Following TAVR Offers Shorter Hemostasis Time Than Suture-based Devices
November 9, 2021 — Results from the largest randomized trial available comparing different closure device strategies…
Read More
Antiplatelet Plavix (Clopidogrel). OPT-PEACE trial found that nearly all patients receiving antiplatelet therapy developed evidence of abnormal gastrointestinal (GI) mucosal findings on capsule endoscopy. GettyImages
November 09, 2021
Most PCI Patients on Antiplatelet Therapy Developed Abnormal Gastrointestinal Findings
November 9, 2021 — Utilizing a magnetically-controlled capsule endoscopy system, the double-blind, randomized OPT-PEACE…
Read More
An illustration of the Recor renal denervation ablation balloon at work in the renal artery.. Renal Denervation Recor RDN ablation balloon #TCT2021
November 09, 2021
Renal Denervation Combined With Medication Can Treat Resistant Hypertension
November 9, 2021 — Six-month outcomes from the randomized RADIANCE-HTN TRIO Trial comparing endovascular ultrasound…
Read More
Abbott's fractional flow reserve (FFR) system. #TCT #TCT21 #FAME3
November 09, 2021
FAME 3 Study Finds FFR Guided PCI Did Not Perform as Well at One-year Compared to Bypass Surgery
November 9, 2021 — The primary results of the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (…
Read More
The Alvimedica Cre8 Evo Cre8 polymer-free amphilimus-eluting stent
November 09, 2021
Patients With Diabetes Undergoing PCI Have Less Target Lesion Failure With Amphilimus-eluting Stents
November 9, 2021 — Results from SUGAR trial, a randomized, controlled, multicenter trial conducted exclusively in…
Read More
TAVR CT image reconstruction of an implanted Medtronic CoreValve. #TCT21 #TCT #TAVR #SURTAVI
November 09, 2021
Intermediate-risk Patients Have Similar Five-year Outcomes With Transcatheter or Surgical Aortic Valve Replacement
November 9, 2021 — New five-year data from the SURTAVI trial found that there was no difference in all-cause mortality…
Read More
A PARTNER 3 trial economic analysis shows for low surgical risk patients, TAVR is cost-saving compared with SAVR. TAVR Sapien Valve visualized using a GE guidance software. #TCT2021
November 09, 2021
TAVR Is Cost Effective Compared With Surgical Replacement for Low-risk Patients
November 9, 2021 — An economic analysis of data from PARTNER 3, a randomized trial comparing transcatheter aortic valve…
Read More
November 09, 2021
QFR Technology for Advanced Coronary Artery Disease Leads to Improved Outcomes
November 9, 2021 — Use of a novel technique called the quantitative flow ratio (QFR) to precisely identify and measure…
Read More
The Cardiologs AI-enabled software being used to remotely monitor a cardiac patient. #Telecardiology, cardiac telehealth
November 09, 2021
Philips Expand Cardiac Diagnostics and Monitoring Portfolio With Cardiologs Acquisition
November 20, 2021 – Philips announced it signed an agreement to acquire Cardiologs, a France-based medical technology…
Read More
Caption Health's AI automated ejection fraction software.
November 09, 2021
Caption Health and Ultromics Partner to Wide Availability of AI-enabled Cardiac Ultrasound Tools
November 9, 2021 — Caption Health and Ultromics, developers of artificial intelligence (AI) to improve cardiac…
Read More
SARS-CoV-2 (COVID-19) virus added to cells. Image from the Institute for Molecular Bioscience, The University of Queensland. Image of the COVID-19 Virus
November 09, 2021
Vascular Disease in COVID-19 is Not Caused by Viral Infection of Blood Vessels
November 9, 2021 — The COVID-19 (SARS-CoV-2) virus does not infect blood vessels, despite the high risk of blood clots…
Read More
A new large-scale, real-world analysis of Centers for Medicare and Medicaid Services (CMS) outcomes data from of peripheral vascular interventions guided by intravascular ultrasound (IVUS) showed a  32% reduction in major adverse limb events, such as amputations, during lower extremity arterial intervention. 
November 09, 2021
IVUS Improved Outcomes in Largest Real-world Analysis of Lower Extremity Peripheral Vascular Interventions
November 9 2021 — A new large-scale, real-world analysis of Centers for Medicare and Medicaid Services (CMS) outcomes…
Read More
The two FDA-cleared transcatheter LAA occlusion devices on the U.S. market were compared in the SWISS-APERO and SEAL FLX trials presented at TCT 2021. Left is the Abbott Amulet device, right is the newest generation Watchman FLX device.
November 08, 2021
First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes
November 8, 2021 – SWISS-APERO is the first randomized clinical trial comparing the Abbott Amulet left atrial appendage…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now